Anca Copaescu (AC) is the founder and CEO of Strategikon Pharma, a SaaS company streamlining key processes in the pharmaceutical industry. In today’s ‘How Did You Do It?’, we sat down with Anca to learn how she was able to successfully build and maintain a pipeline of 13 million within the pharmaceutical industry.
Interviewee: Anca Copaescu (AC)
Interviewer: Stefani Rios (TCA)
TCA: Anca, what is Clinical Maestro? What are some benefits?
AC: Clinical Maestro is a software solution that automates R & D Procurement, the process of planning and managing clinical trials for pharmaceutical companies. Measuring the speed at which you can perform an activity in Excel versus our solution and we’ve been seeing more than 95% reduction in the time allocated to perform an activity. Giving customers an average of 10x ROI.
TCA: How did you build the 13 million pipeline?
AC: By maximizing exposure as much as we could and focusing on thought leadership. Thought leadership has been the best way to drive our sales. Our pipeline was built by highlighting the problem and having the customer or well known field experts speak about the solution in a personal matter. With little to no marketing, the customer is the start and allows them to do the business development. In a room of 50 people listening to me talk to an expert, 10% of the room converts into leads.
TCA: How do you maintain the 13 million pipeline?
AC: We knew the pharma persona very well and focused on users that would have the fastest adoption and nurtured these customers. By prioritizing the value proposition and customers, Strategikon Pharma gained 60% of customers from word-of-mouth referrals. Including CSL Behring, Astellas, Vertex companies like Insight, Novavax and other significant logos in the mid to large pharma segment.
Disclaimer:
The views, information, or opinions expressed during the interview series is solely those of the individuals involved and do not necessarily represent those of Tech Coast Angels and its employees, consultants and interns. Tech Coast Angels is not responsible and does not verify for accuracy any of the information contained in the podcast series available for listening on this site. The primary purpose of this interview series is to inform. This Interview series does not constitute medical or other professional advice or services.